Rare diseases
Investigational molecules
Locations
Study Comparing Bictegravir/Lenacapavir to Current Therapy in People with HIV-1 Who Are Successfully Treated
FranceStudy on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
AustriaStudy Comparing Integrase Inhibitor (Bictegravir) and Boosted Protease Inhibitor (Darunavir) Treatments for Patients with Advanced HIV Infection
BelgiumStudy on Switching HIV Treatment to Dolutegravir/Lamivudine in Patients Aged 50+ with Virologic Suppression
AustriaStudy on the Safety of Tenofovir Alafenamide and Natalizumab for People with Multiple Sclerosis
NorwayStudy Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in Adults New to Antiretroviral Therapy
BelgiumStudy on the Effectiveness of Rilpivirine-Based Treatment for HIV Patients with Metabolic Liver Disease Using Dolutegravir, Rilpivirine, and Emtricitabine/Tenofovir Combination
SpainStudy Comparing Two Drug Regimens for HIV: Lamivudine and Dolutegravir Sodium vs. Emtricitabine, Tenofovir Alafenamide, and Bictegravir in HIV-Positive Patients
BelgiumStudy on the Effects of Abacavir Sulfate and Etravirine in Pregnant Women with HIV
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
